|
93
|
In Vivo Characterizations--Prioritizations for Phase II caNanoLab Enhancements
As part of the Phase II caNanoLab enhancements, we would like to add metadata for in vivo characterizations to the relevant pull-down menus of the web-based data submission forms. It would be very helpful if you could help us prioritize which in vivo characterizations should be added to the submission forms (i.e., toxicology, pharmacokinetics (PK), efficacy, animal/treatment, imaging), as well as the concepts (measurements and assays) that are most applicable to your research and the biomedical nanotechnology field in general. A file containing concepts associated with each of these characterizations can be found at https://nciphub.org/projects/nanoinvivo/files/ for your review and feedback in this discussion.
|
1
Discussions
|
1
Posts
|
